ALEXANDRIA, Va., July 23 -- United States Patent no. 12,366,570, issued on July 22, was assigned to The Johns Hopkins University (Baltimore).
"Cell-based ZNT8 assay" was invented by Dax Fu (Short Hills, N.J.) and Chengfeng Merriman (Essex, Md.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to the fields of immunology and diabetes. More specifically, the present invention provides methods and compositions directed to the use of antibodies to quantify cellular pancreatic zinc transporter 8. In certain embodiment, the present invention provides methods and compositions directed to the use of antibodies to screen for modulators of the pancreatic zinc transporter, ZnT8. In one embodi...